These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21610159)

  • 1. Endoplasmic reticulum stress response in P104L mutant caveolin-3 transgenic mice.
    Kuga A; Ohsawa Y; Okada T; Kanda F; Kanagawa M; Toda T; Sunada Y
    Hum Mol Genet; 2011 Aug; 20(15):2975-83. PubMed ID: 21610159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
    Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
    J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The caveolin-3 P104L mutation in LGMD-1C patients inhibits non-insulin-stimulated glucose metabolism and growth but promotes myocyte proliferation.
    Shang L; Chen T; Xian J; Deng Y; Huang Y; Zhao Q; Liang G; Liang Z; Lian F; Wei H; Huang Q
    Cell Biol Int; 2019 Jun; 43(6):669-677. PubMed ID: 30958599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the muscular dystrophy-associated caveolin-3(P104L) mutant in adult mouse skeletal muscle specifically alters the Ca(2+) channel function of the dihydropyridine receptor.
    Weiss N; Couchoux H; Legrand C; Berthier C; Allard B; Jacquemond V
    Pflugers Arch; 2008 Nov; 457(2):361-75. PubMed ID: 18509671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and pathological changes result from mutated Caveolin-3 in muscle.
    González Coraspe JA; Weis J; Anderson ME; Münchberg U; Lorenz K; Buchkremer S; Carr S; Zahedi RP; Brauers E; Michels H; Sunada Y; Lochmüller H; Campbell KP; Freier E; Hathazi D; Roos A
    Skelet Muscle; 2018 Aug; 8(1):28. PubMed ID: 30153853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-3 deficiency associated with the dystrophy P104L mutation impairs skeletal muscle mitochondrial form and function.
    Shah DS; Nisr RB; Stretton C; Krasteva-Christ G; Hundal HS
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):838-858. PubMed ID: 32090499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Caveolin-3 P104L mutation of LGMD-1C leads to disordered glucose metabolism in muscle cells.
    Deng YF; Huang YY; Lu WS; Huang YH; Xian J; Wei HQ; Huang Q
    Biochem Biophys Res Commun; 2017 Apr; 486(2):218-223. PubMed ID: 28232187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inhibitor of transforming growth factor beta type I receptor ameliorates muscle atrophy in a mouse model of caveolin 3-deficient muscular dystrophy.
    Ohsawa Y; Okada T; Nishimatsu S; Ishizaki M; Suga T; Fujino M; Murakami T; Uchino M; Tsuchida K; Noji S; Hinohara A; Shimizu T; Shimizu K; Sunada Y
    Lab Invest; 2012 Aug; 92(8):1100-14. PubMed ID: 22584670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells.
    Smythe GM; Rando TA
    Exp Cell Res; 2006 Sep; 312(15):2816-25. PubMed ID: 16814768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells.
    Couchoux H; Allard B; Legrand C; Jacquemond V; Berthier C
    J Physiol; 2007 May; 580(Pt.3):745-54. PubMed ID: 17317753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity.
    Ohsawa Y; Toko H; Katsura M; Morimoto K; Yamada H; Ichikawa Y; Murakami T; Ohkuma S; Komuro I; Sunada Y
    Hum Mol Genet; 2004 Jan; 13(2):151-7. PubMed ID: 14645200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy.
    Müller JS; Piko H; Schoser BG; Schlotter-Weigel B; Reilich P; Gürster S; Born C; Karcagi V; Pongratz D; Lochmüller H; Walter MC
    Neuromuscul Disord; 2006 Jul; 16(7):432-6. PubMed ID: 16730439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of caveolin-3 protein is limited in damaged muscle in chicken muscular dystrophy.
    Matsumoto H; Sasazaki S; Fujiwara A; Ichihara N; Kikuchi T; Mannen H
    Comp Biochem Physiol A Mol Integr Physiol; 2010 Sep; 157(1):68-72. PubMed ID: 20451648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-3 is a direct molecular partner of the Cav1.1 subunit of the skeletal muscle L-type calcium channel.
    Couchoux H; Bichraoui H; Chouabe C; Altafaj X; Bonvallet R; Allard B; Ronjat M; Berthier C
    Int J Biochem Cell Biol; 2011 May; 43(5):713-20. PubMed ID: 21262376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy.
    Davies JE; Sarkar S; Rubinsztein DC
    Hum Mol Genet; 2006 Jan; 15(1):23-31. PubMed ID: 16311254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-3 regulates myostatin signaling. Mini-review.
    Ohsawa Y; Okada T; Kuga A; Hayashi S; Murakami T; Tsuchida K; Noji S; Sunada Y
    Acta Myol; 2008 Jul; 27(1):19-24. PubMed ID: 19108573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
    Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
    Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis of seipin/BSCL2-related motor neuron diseases.
    Ito D; Suzuki N
    Ann Neurol; 2007 Mar; 61(3):237-50. PubMed ID: 17387721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N88S seipin mutant transgenic mice develop features of seipinopathy/BSCL2-related motor neuron disease via endoplasmic reticulum stress.
    Yagi T; Ito D; Nihei Y; Ishihara T; Suzuki N
    Hum Mol Genet; 2011 Oct; 20(19):3831-40. PubMed ID: 21750110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.